Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

JACC Debuts Data Digest on CV Health in the United States

News Daily News

JACC Debuts Data Digest on CV Health in the United States

January 12, 2026

January 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

January 01, 2024

September 2023 News Roundup

News Opinion CV Team Dispatch

September 2023 News Roundup

September 01, 2023

April 2023 News Roundup

News Opinion CV Team Dispatch

April 2023 News Roundup

April 01, 2023

February 2022 News Roundup

News Opinion CV Team Dispatch

February 2022 News Roundup

February 01, 2022

PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF

News Conference News HFSA 2021

PRESERVED-HF: Dapagliflozin Improves Symptoms, Physical Limitations in HFpEF

September 13, 2021

From Excess Amputations to Postpregnancy HF, Studies Shine Light on Racial Divide

News Daily News

From Excess Amputations to Postpregnancy HF, Studies Shine Light on Racial Divide

September 06, 2021

TCTMD’s Top 10 Most Popular Stories for December 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2020

December 31, 2020

add story title

News Opinion Editor's Corner

Envision Change: A Different Future for Cardiology, Medicine, Research, and Health

December 29, 2020

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

April 29, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2020

January 31, 2020

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

News Daily News

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

December 06, 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

September 16, 2019

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

News Conference News AHA 2018

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

November 10, 2018

CANVAS Analysis Provides Heart Failure Reassurances for Canagliflozin

News Conference News

CANVAS Analysis Provides Heart Failure Reassurances for Canagliflozin

Michael O'Riordan

March 16, 2018

How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues

News Daily News

How SGLT2 Inhibitors Help the Heart: Biomarker Study Offers Clues

August 01, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.